Abstract:A recombinant human parathyroid hormone fragment, Pro-Pro-hPTH(1-34), with molecular weight of 4311.46 was acquired through gene engineering. It was then isolated and purified. The homogeneity of this fragment was characterized by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), high performance liquid chromatography(HPLC), isoelectronic focusing (IEF) electrophoresis and mass spectrometry(MS) methods. Its isoelectric point is 8.0 which was determined by IEF. It was found that the hormone fragment significantly induced calcium increment as compared to the control group (P<0.001) in Parsons's Chicken Assay, an established bioassay for the evaluation of the PTH effect. After the 3-month-old ovariectomized (OVXed) rats, the OVXed rat is one of the two models required by the U.S. Food and Drug Administration for the preclinical assessment of drugs for treating osteoporosis [DeLuca PP, Dani BA. Skeletal effects of parathyroid hormone (1-34) in ovariectomized rats with or without concurrent administration of salmon calcitonin. Am Assoc Pharm Sci 2001;3(4):E27 [1]]. Sprague-Dawley rats were fed for 14 weeks, daily subcutaneous injections of Pro-Pro-hPTH(1-34) for 16 weeks (0.4, 0.6 or 0.9 nmol/100 g body weight), reduced the ovariectomy (OVX)-triggered mass loss of vertebral trabecular bone. The mean Bone Material Density (BMD) increased to 29.2-34.5% in 3-month-old OVXed rats compared to control-vehicle group (P<0.001) and increased to 17.5-22.3% compared to sham-operated groups (P<0.01). In short, A recombinant Pro-Pro-hPTH(1-34) was harvested in purified form and its physico-chemical characterization was determined. It showed significantly enhanced activity upon two typical models for PTH fragments. It can increase the mineral density of vertebral trabecular bone just as synthetic hPTH(1-34), and the functional activity of Pro-Pro-hPTH(1-34) should be due to the removing of Pro-Pro- by Dipeptidyl peptidase IV (DPPIV). This study opened out a simplified method which was cheaper, faster than the conventional one for producing active hPTH fragment, and its applied prospect would be good; Furthermore, it may open up our own path in finding new methods for post-processing of gene-engineering product.

Secretory Expression and Scale-Up Production of Recombinant Human Thyroid Peroxidase Via Baculovirus/insect Cell System in a Wave-Type Bioreactor.

Extracellular Production of Human Parathyroid Hormone As a Thioredoxin Fusion Form in Escherichia Coli by Chemical Permeabilization Combined with Heat Treatment.

A rapid assay of human thyroid peroxidase activity

Glycosylation of Recombinant Human Thyroid Peroxidase Ectodomain of Insect Cell Origin Has Little Effect on Recognition by Serum Thyroid Peroxidase Antibody.

Large Scale Preparation of Recombinant Human Parathyroid Hormone 1–84 from Escherichia Coli

Construction of highly efficient expression plasmid,its protein expression and purification of the functional human thyrotropin receptor ectodomain

Expression, Purification, and Characterization of A Novel Recombinant Fusion Protein, Rhtpo/Scf, in Escherichia Coli

Stable Expression of the Human TSH Receptor in CHO Cells and the Functional Assessment

Molecular Characterization of Thyroid Peroxidase Gene in Porcine (sus Scrofa)

Construction,expression and Characterization of Recombinant Fusion Protein HSA-PTH(1-34) in Pichia Pastoris

Development and validation of a novel reporter gene assay for determination of recombinant human thrombopoietin

Prokaryotic expression of thyroid hormone-response protein-1 gene

Functional Expression of Human Serum Albumin-Tandem Thrombopoietin Mimetic Peptide Fusion Protein As A Novel Thrombopoietin Analog in Pichia Pastoris

Partial purification of human parathyroid hormone 1-84 as a thioredoxin fusion form in recombinant Escherichia coli by thermoosmotic shock.

Synergistic promotion of transient transgene expression in CHO cells by PDI/XBP-1s co-transfection and mild hypothermia

Simple and rapid in vitro assay for detecting human thyroid peroxidase disruption

Study on preparation and activity of a novel recombinant human parathyroid hormone(1-34) analog with N-terminal Pro-Pro extension.

Mammary Gland-specific Expression Vectors with Intron Ⅴ of the Human Thrombopoietin Gene Facilitate Its High-level Expression in HC-11 cells

Cloning of human thrombopoietin and it's expression in E. coli

Enhanced Production of Secretory Glycoprotein VSTM1-v2 with Mouse IgGκ Signal Peptide in Optimized HEK293F Transient Transfection.

Stable Expression of Pcdna3.1-Htshr in CHO Cells